A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects
Status:
Completed
Trial end date:
2019-05-07
Target enrollment:
Participant gender:
Summary
The investigators are doing this study to find out if tucatinib is safe for patients with
liver problems. This study will look at participants with mild, moderate, and severe liver
problems. For each participant with liver problems who takes part, a matching healthy
participant who is of similar age, similar body mass index (BMI), and of the same sex will
also take part. The study will look at how the drug affects healthy participants compared to
participants with liver problems.